Narcolepsy: genetic predisposition and neuropharmacological mechanisms
Authors:
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Sleep Medicine Reviews
- Vol. 4 (1) , 57-99
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Neuropharmacological Characterization of Basal Forebrain Cholinergic Stimulated Cataplexy in Narcoleptic CaninesExperimental Neurology, 1998
- HLA class II analysis in Jewish Israeli narcoleptic patientsHuman Immunology, 1995
- Effects of Modafinil on Symptomatology of Human NarcolepsyClinical Neuropharmacology, 1993
- Narcolepsy without unique MHC class II antigen association: Studies in the canine modelHuman Immunology, 1989
- Nocturnal γ-HydroxybutyrateClinical Neuropharmacology, 1989
- Problems and Coping Strategies Identified by Narcoleptic PatientsJournal of Neuroscience Nursing, 1984
- Narcolepsy: Cholinergic receptor changes in an animal modelLife Sciences, 1984
- Activity of substantia nigra units across the sleep-waking cycle in freely moving catsNeuroscience Letters, 1981
- The central stimulatory action of inhibitors of the dopamine uptakeLife Sciences, 1979
- Electroencephalographic analyses of amphetamine and its methoxy derivatives with reference to their sites of EEG alerting in the rabbit brainInternational Journal of Neuropharmacology, 1969